DOCSLIB.ORG

1 Liste Des 3000 Ingrédients Controversés Évités Par

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1 Liste Des 3000 Ingrédients Controversés Évités Par LISTE DES 3000 INGRÉDIENTS CONTROVERSÉS ÉVITÉS PAR MODERE 1 SOINS PERSONNELS Conformément au paradigme des ingrédients de MODERE, la compagnie exclu une liste de plus de 3000 ingrédients controversés différents à éviter dans les formulations de ses produits. Chaque année, les chercheurs publient de nouvelles informations sur les ingrédients des produits. Modere convoque régulièrement son Scientific Advisory Board (Conseil Consultatif Scientifique) afin de : - réexaminer la science qui se cache derrière certains ingrédients et - donner des recommandations sur l'utilisation que Modere fait de ces ingrédients. Cependant, quand de nouveaux ingrédients sont ajoutés à sa liste, il est possible que certains éléments faisant partie de la large gamme de produits MODERE contiennent ces nouveaux ingrédients controversés. Ainsi, Modere doit entamer le processus de reformulation qui prend un certain temps à développer et à implémenter. Malheureusement, en raison de ces processus continus de découvertes, d'évaluations et de reformulations, MODERE ne sera respectera peut être pas toujours sa liste d'ingrédients controversés à 100%. Nous sommes cependant fiers de la position de leader que Modere occupe dans cette industrie, et nous sommes confiants que les produits Modere garantissent de manière jusqu'à présent inégalée la sécurité de nos consommateurs. Modere évite les formulations dans ses soins personnels avec des ingrédients tels que : (2-Isopropylpent.4-Enoyl) 2,2,6-Trimethyl-4-piperidyl 2-Methyl-m- urée (apronalide) benzoate (benzamine) phenylenediamine [4-(4-Hydroxy-3- 2,2,6-Trimethyl-4-piperidyl 2-Naphthol iodophenoxy)-3,5- benzoate (benzamine) sels 3-(1-Naphthyl)4- diiodophenyl]acide 2,3,7,8- Hydroxycoumarin acétique et ses sels Tetrachlorodibenzo-p- 3,4,5- 1,2-epoxybutane Dioxin (TCDD) Trimethyoxyphenethylami 1,3-dimethylpentylamine 2,3-Dichloro-2- ne et ses sels methylbutane 3,-ethyl-5',6',7,8'- 11 Hydroxypregn-4-ene- 2,4-diaminoanisole tetrahydro-5',6',8,8'- 3,20-dione 2,4-diaminophenylethanol tetramethyl-2'- aceto- 1-Butyl-3-(N- 2-[4-methoxybenzyl-N-(2- naphthone crotononylsulphanilyl) pyridyl)amino]ethyldimeth 3-Diethylaminopropyl urée lamine maleate Cinnamate 1-Dimethylaminomethyl- 2-5-diaminoanisol 4,4'-Dihydroxy-3,3-(3- 1-methylpropyl benzoate 2- methylthiopropylidene) (amylocaine) Acetoxyethyltrimethylam Dicoumarin 1-Dimethylaminomethyl- monium hydroxide 4-Amino-2-nitrphenol 1-methylpropyl benzoate (acetylcholine) et ses sels 4-Aminobenzoic Acide (amylocaine) sels 2-Amino-1,2-bis(4- 4-Aminosalicylic acid et ses 1-Naphthylamine2- methoxyphenyl)ethanol et sels Naphthylamine ses sels 4-Benzyloxyphenol4- 2-(4-Allyl-2- 2-Amino-4-nitrophenol ethoxy-m- methoxyphenoxy)-N,N- 2-Amino-5-nitrophenol phenylenediamine diethylacetamide 2-Diethylaminoethyl-3- 4-Ethoxyphenol 2,2,2-Trichloroethane-1,1- hydroxy-4-phenylbenzoate 4-hydroxy-3- diol 2-Methylheptylamine methxycinnamyl Alcohol 2 4-Methoxyphenol Acrylates/Ceteth-20 Aluminum Butoxide 4-methyl-m- Itaconate Copolymer Aluminum Calcium Sodium phenylenediamine Acrylates/Ceteth-20 Silicate 4-Phenylbut-3-en-2-one Methacrylate Copolymer Aluminum Caprylate 4-tert-butylphenol Acrylates/Laureth-25 Aluminum Capryloyl 4-tert-Butylpyrocatechol Methacrylate Copolymer Hydrolyzed Collagen 5-(α,β,- Acrylates/Methoxy PEg-15 Aluminum Chloride Dibromophenethyl)-5- Methacrylate Copolymer Aluminum Chlorohydrate methylhydantoin Acrylates/Methoxy PEg-23 Aluminum Chlorohydrex 5,5'-Di-idopropyl-2,2'- Methacrylate/Perfluorooc Aluminum Chlorohydrex dimethylbiphenyl-4,4'-diyl tyl Ethyl PEG Dihypoiodite Acrylate Copolymer Aluminum Chlorohydrex 5,5-Diphenyl-4- Acrylates/PEg-10 PG Imidazolidone Maleate/Styrene Aluminum Citrate 5-methoxypsoralen Copolymer Aluminum Diacetate 8-methoxypsoralen Acrylates/PEg-4 Aluminum Acenocoumarol Dimethacrylate Dibenzoate/Stearate Acetamide MEA Crosspolymer Hydroxide Acetonitrile Acrylates/Steareth-20 Aluminum Dicetyl Acetylcholine Itaconate Copolymer Phosphate Acetylene Chloride Acrylates/Steareth-20 Aluminum Acid Blue 74 Aluminum Methacrylate Copolymer Dichlorohydrate Lake Acrylates/Steareth-20 Aluminum Dichlorohydrex Acid Blue 9 Aluminum Lake Methacrylate PEG Acid Red 14 Aluminum Crosspolymer Aluminum Dichlorohydrex Lake Acrylates/Steareth-50 PG Acid Red 18 Aluminum Acrylate Copolymer Aluminum Dilinoleate Lake Acrylic Resin Coated Aluminum Dimyristate Acid Red 27 Aluminum Aluminum Powder Aluminum Distearate Lake Adansonia Digitata Seed Aluminum Fluoride Acid Yellow 23 Aluminum Oil PEg-8 Esters Aluminum glycinate Lake Adipic Acid/Methyl DEA Aluminum Hydrogenated Acid Yellow 3 Aluminum Crosspolymer Tallow glutamate Lake Adipic Acid/PPg-10 Aluminum Hydroxide Aconitine Copolymer Aluminum Hydroxy Bis- Aconitine (principal Adonis vernalis L. et ses Methylene Bis-Di-t- alkaloid of Aconitum préparations Butylphenyl Phosphate napellus L.) Alkali Aluminum Iron Calcium Aconitine (principal Pentasyanonitrosylferrate Magnesium germanium alkaloid of Aconitum (2-) Silicates napellus L.) salts Alkyne Alcohols Aluminum Isostearate Aconitum Napellus L. Alkyne alcohols, leurs Aluminum Aconitum napellus L. esters, éthers et sels Isostearates/Laurates/Pal (leaves, roots and galenical Alloclamide and ses sels mitates preparations) Allyl isothiocyanate Aluminum Acrylamides/DMAPA Allyl Isothiocynate Isostearates/Laurates/Stea Acrylates/Methoxy PEg Almond Oil PEg-6 Esters rates Methacrylate Copolymer Almond Oil PEg-8 Esters Aluminum Acrylates/Aminoacrylates/ Almond Oil Propylene Isostearates/Myristates C10-30 Alkyl PEg-20 Glycol Esters Aluminum Itaconate Copolymer Almondamide DEA Isostearates/Palmitates Acrylates/Beheneth-25 Aluminum Acetate Aluminum Methacrylate Copolymer Aluminum Acetate Isostearates/Stearates Acrylates/Beheneth-25 Solution Aluminum Isostearyl Methacrylate/Steareth-30 Aluminum Behenate Glyceryl Phosphate Methacrylate Copolymer Aluminum Benzoate Aluminum Laccate Aluminum Bromohydrate Aluminum Lactate 3 Aluminum Lanolate Aminocaproic acid and its Apricot kernel Oil PEg-8 Aluminum Magnesium salts Esters Oxide Amitriptylilne Apricotamide DEA Aluminum Metal Ammi majus and its Arecoline Aluminum Methionate galenical preparations Argan Oil PEg-8 Esters Aluminum Myristate Ammonium Aristolochic Acid Aluminum Acryloyldimethyltaurate/L Arsenic and its compounds Myristates/Palmitates aureth-7 Methacrylate Astrocaryum Vulgare Oil Aluminum PCA Copolymer PEG-8 Esters Aluminum Ammonium Atropa belladonna L. and Phenolsulfonate Acryloyldimethyltaurate/S its preparations Aluminum Powder teareth-25 Methacrylate Atropine, its salts and Aluminum Crosspolymer derivatives Sesquichlorohydrate Ammonium Avocadamide DEA Aluminum Acryloyldimethyltaurate/S Avocado Oil PEg-11 Esters Sesquichlorohydrex PEG teareth-8 Methacrylate Avocado Oil PEg-8 Esters Aluminum Copolymer Avocado Oil Propylene Sesquichlorohydrex PG Ammonium C12-15 Pareth Glycol Esters Aluminum Silicate Sulfate Azacyclonol Aluminum Starch Ammonium Dimethicone Azamethonium Bromide Octenylsuccinate PEG-7 Sulfate (AkA: Pentamines) Aluminum Stearate Ammonium Laureth Babassuamide DEA Aluminum Stearates Sulfate Barbiturates Aluminum Stearoyl Ammonium Laureth-12 Barium salts, with the Glutamate Sulfate exception of barium Aluminum Sucrose Ammonium Laureth-5 sulphate, barium sulphide Octasulfate Sulfate Behenamide DEA Aluminum Sulfate Ammonium Laureth-6 Behentrimonium Aluminum Triformate Carboxylate Dimethicone PEg-8 Aluminum Triphosphate Ammonium Laureth-7 Phthalate Aluminum Tristearate Sulfate Bemegride Aluminum Undecylenoyl Ammonium Laureth-8 Benactyzine Collagen Amino Acids Carboxylate Bendroflumethiazide and Aluminum Zinc Oxide Ammonium Laureth-9 its derivatives Aluminum Zirconium Sulfate Benzamine Octachlorohydrate Ammonium Silver Zinc Benzatropine Aluminum Zirconium Aluminum Silicate Benzazepines and Octachlorohydrex gLY Amydricaine Alypine benzodiazepines Aluminum Zirconium Amyl Nitrate Benzazpine Pentachlorohydrate Anamirta Cocculuc L. Benzene Aluminum Zirconium Aniline Benzidine Pentachlorohydrex gLY Aniline halogenated Benzilonium bromide Aluminum Zirconium derivatives Benzilonium Bromide Tetrachlorohydrex gLY Aniline salts Benzimidazol-2(3H)-one Aluminum Zirconium Aniline sulphonated Benzodiazepine Tetrachlorohydrex PEG derivatives Benzoyl Peroxide Aluminum Zirconium Anthracene Oil Benzyl Alcohol Tetrachlorohydrex PG Antimony and its Benzylparaben Aluminum Zirconium compounds Bertholletia Excelsa Seed Trichlorohydrate Apocynum cannabinum L. Oil PEg-8 Esters Aluminum/Dysprosium/Eu and its preparations Beryllium (Metalloid) ropium/Strontium Oxide Apomorphine (R 5,6,6a, 7- Beryllium and its Aluminum/Magnesium tetrahydro-6-methyl-4H- compounds Hydroxide Stearate dibenzo [de,g] Apricot Betoxycaine and its salts Ambenomium Chloride Kernel Oil PEG-40 Esters BHC-ISO Aminocaproic Acid Apricot kernel Oil PEg-6 Bis(PPg-7 Undeceneth-21) Esters Dimethicone 4 Bis-Adamantanyl PEg-200 Bis-PEG-12 Dimethicone C11-13 Pareth-6 Dicarboxamide Beeswax C11-13 Pareth-9 Bis-Adamantyl PEG-800 Bis-PEG-12 Dimethicone C11-15 Pareth-12 Dicarboxamide Candelillate C11-15 Pareth-12 Stearate Bisamino PEg/PPg-41/3 Bis-PEg-15 C11-15 Pareth-15 Aminoethyl Pg-Propyl Dimethicone/IPDI C11-15 Pareth-20 Dimethicone Copolymer C11-15 Pareth-3 Bis- Bis-PEG-15 Methyl Ether C11-15 Pareth-3 Oleate Butyloxyamodimethicone/ Dimethicone C11-15 Pareth-3 Stearate PEG-60 Copolymer Bis-PEG-18 Methyl Ether C11-15 Pareth-30 Bis-C12-14 Pareth-3/C16- Dimethyl Silane C11-15 Pareth-40 20 Pareth-11 HDI/PEG-130 Bis-PEG-20 Dimethicone C11-15 Pareth-5 Copolymer Bis-PEG-4 Dimethicone C11-15 Pareth-7 Bis-Cetyl/PEg-8
Load more

Recommended publications
  • IIIHIIIUSOO5304377A Unitedo States Patent 19 (11) Patent Number: 5,304,377 Yamada Et Al
    IIIHIIIUSOO5304377A UnitedO States Patent 19 (11) Patent Number: 5,304,377 Yamada et al. (45) Date of Patent: Apr. 19, 1994 54 PROLONGED RELEASE PREPARATION 4,954,298 9/1990 Yamamoto et al. ................. 264/4.6 AND POLYMERS THEREOF 4,962,091 10/1990 Eppstein et al. ........................ 514/2 75) Inventors: Minoru Yamada; Seiko Ishiguro, both 5,061,492 10/1991 Okada et al. ........................ 424/423 Otokuni, all of Japan 0052510 11/1981 European Pat. Off. 73) Assignee: Sherical4. industries, Ltd., O256726O190833 7/19871/1986 European Pat. Off. a, Japan 0263490 10/1987 European Pat. Off. (21) Appl. No.: 986,299 0281482 3/1988 European Pat. Off. 035.0246 7/1989 European Pat. Off. 22 Filed: Dec. 7, 1992 2-212436 8/1990 Japan. Related U.S. Application Data OTHER PUBLICATIONS 63) continuation of ser. No. 777,170, oct. 16, 1991, aban- Chemical Abstracts, vol. 114/No. 6 (Feb. 11, 1991); doned. Columbus, Ohio; Abstract No. 49615R. 30 Foreign Application Priority Data Primary Ent, S. Sir Mueller & Oct. 16, 1990 (JP) Japan .................................. 2-278037 story Agent, or Firm-Wegner, Cantor, Mueller Aug. 28, 1991 JP Japan .................................. 3.217045 51 Int, Cl. ......................... A61K 9/22; A61K 9/52; ' ABSTRACT A61K 31/74 A polymer for a prolonged release preparation which 52 U.S. Cl. ................................. 424/426; 424/78.08; comprises 424/78.37; 424/434; 424/457; 424/468; (A) a polylactic acid and 424/486; 424/497; 525/450, 514/2 (B) a copolymer of glycolic acid and a hydroxycar 58) Field of Search .................. 424/426, 78.08, 78.37, boxylic acid of general formula 424/434, 457, 468, 486, 497; 525/450; 514/2 (56) References Cited R U.S.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Col.V.MISSION of the EUROPEAN COMMUNITIES
    COl.V.MISSION OF THE EUROPEAN COMMUNITIES SEC(90) 1985 final· Brussels, 29 October 1990 Proposa I for a COUNCIL DIRECTIVE on the approximation of the laws of the Member States relat.ing to cosmetic products -2- EXPLANATORY UEUORANDUM 1. In the context of a people's Europe, the Commission attaches great Importance to simplifying and clarifying Community law so as to make It clearer and more accessible to the ordinary citizen, thus giving hIm new opportunItIes and the chance to make use of the spec if i c rights It gives him. This aim cannot be achieved so long as numerous provisions that have been amended several times, often QUite substantially, remain scattered, so that they must be sought partly In the original Instrument and partly In later amending ones. Considerable research work, comparing many different Instruments, Is thus needed to Identify the current rules. For this reason a consot tdatton of rules that have freQuently been amended Is essential If Community law Is to be clear and transparent. 2. In Its resolution of 26 November 1974 concerning consolidation of Its acts (1), the Council recommended that those of Its acts which have been amended several times be assembled Into a single text. It stressed that, In the Interests of legal certainty, a genuine legislative consolidation, Involving the repeal of earlier acts, should wherever possible be effected (as Is being done In this case). it conseQuently Invited the Commission to let it have proposals for consol !dation and undertook ·to examine them "as Quickly as possible, whltout bringing Into QUestion, during that consol ldatlon, the substantive solutions contained In the consol !dated texts".
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Prolonged Release Microparticle Preparation and Production of the Same
    Europaisches Patentamt 19 European Patent Office Office europeen des brevets © Publication number : 0 535 937 A1 12 EUROPEAN PATENT APPLICATION (2j) Application number : 92308924.7 © int. ci.5: A61K 9/50, A61K 9/16 (22) Date of filing : 30.09.92 © Priority: 01.10.91 JP 253517/91 (72) Inventor : Takada, Shigeyuki No. 1511 University Village Salt Lake City, Utah 84108 (US) @ Date of publication of application Inventor : Ogawa, Yasuaki 07.04.93 Bulletin 93/14 77-42, Koaza-tanita, Aza-ohyamazaki Ohyamazaki-cho, Otokuni-gun, Kyoto 618 (JP) Inventor : Uda, Yoshiaki @ Designated Contracting States : 2-501, 3 Nikawadanchi, Takarazuka AT BE CH DE DK ES FR GB GR IE IT LI LU NL Hyogo 665 (JP) PT SE (74) Representative : Laredo, Jack Joseph @ Applicant : TAKEDA CHEMICAL INDUSTRIES, Elkington and Fife Prospect House 8 LTD. Pembroke Road 1-1, Doshomachi 4-chome Sevenoaks, Kent TN13 1XR (GB) Chuo-ku, Osaka 541 (JP) (54) Prolonged release microparticle preparation and production of the same. (57) A novel microparticle preparation comprising microparticles of a polymer which contain a drug and are coated with a film of an agent for preventing aggregation of the microparticles is disclosed. The preparation is produced by spraying a solution of a polymer containing a drug and an aqueous solution of an agent for preventing aggregation of the microparticles separately from different nozzles and contacting them with each other in a spray dryer. If) CO If) LU Jouve, 18, rue Saint-Denis, 75001 PARIS EP 0 535 937 A1 FIELD OF THE INVENTION The present invention relates to a microparticle preparation comprising microparticles of a polymer which contain a drug and are coated with a film of an agent for preventing aggregation of the microparticles (here- 5 inafter sometimes referred to as a microparticle preparation) and the production thereof by spray drying.
    [Show full text]
  • Annexes of the Asean Cosmetic Directive
    Annex II Part 1 – List of substances which must not form part of the composition of cosmetic products ANNEXES OF THE ASEAN COSMETIC DIRECTIVE Annex II Part 1: List of substances which must not form part of the composition of cosmetic products Annex III – Part 1 List of substances which cosmetic products must not contain except subject to restrictions and conditions laid down Annex III – Part 2 List of substances provisionally allowed Annex IV – Part 1 List of colouring agents allowed for use in cosmetic products Annex VI List of preservatives allowed Annex VII List of permitted UV filters which cosmetic products may contain Revision as per August 2015 ASEAN Cosmetic Documents 1 Annex II Part 1 – List of substances which must not form part of the composition of cosmetic products Annex II Part 1 List of substances which must not form part of the composition of cosmetic products Substances CAS Number Ref. No Aminophylline 317-34-0 A1136 Theophylline 58-55-9 A1137 Methylene chloride (Dichloromethane) 75-09-2 A1138 Chlorofluorocarbons - A1139 Diethylene glycol (except if it is present as unavoidable trace limit 111-46-6 A1140 of 0.1% in finished product) Azelaic acid 123-99-9 A1141 Bimatoprost 155206-00-1 A1142 N-5-Chlorobenzoxazol-2-ylacetamide 35783-57-4 1 2-Acetoxyethyltrimethylammonium hydroxide (acetylcholine) 51-84-3/2260- and its salts 50-6/927-86- 2 6/66-23-9/60- 31-1 Deanol aceglumate (INN) 3342-61-8 3 Spironolactone (INN) 52-01-7 4 [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl] acetic acid and 51-24-1 5 its salts Methotrexate (INN) 59-05-2 6 Aminocaproic acid (INN) and its salts 60-32-2 7 Cinchophen (INN), its salts, derivatives and salts of these 132-60-5 8 derivatives Thyropropic acid (INN) and its salts 51-26-3 9 Trichloroacetic acid 76-03-9 10 Aconitum napellus L.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Pharmaceutical Appendix to the Harmonized Tariff Schedule
    Harmonized Tariff Schedule of the United States Basic Revision 3 (2021) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States Basic Revision 3 (2021) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Prolonged Release Preparation and Polymers Thereof
    iiililiili^ @ EuroPean Patent Office ^-S Office europeen des brevets (fi) Publication number : 0 481 732 A1 @ EUROPEAN PATENT APPLICATION @ Application number: 91309490.0 @ Int. CI.5: A61K 9/16, A61K 9/50, A61K9/52, A61K9/20 (22) Date of filing : 15.10.91 (30) Priority : 16.10.90 JP 278037/90 (72) Inventor : Yamada, Minoru 28.08.91 JP 217045/91 1- 8, Yuyamadai 1-chome Kawanishi, Hyogo 666-01 (JP) Inventor : Ishiguro, Seiko (43) Date of publication of application : 2- 86, Seiwadainishi 3-chome 22.04.92 Bulletin 92/17 Kawanishi, Hyogo 666-01 (JP) Inventor : Ogawa, Yasuaki 77-42, Koaza-tanita, Aza-ohyamazaki States @ Designated Contracting : Ohyamazaki-cho, Otokuni-gun, Kyoto 618 (JP) AT BE CH DE DK ES FR GB GR IT LI LU NL SE (74) Representative : Lewin, John Harvey TAKEDA CHEMICAL © Applicant : INDUSTRIES, Elkington and Fife Prospect House 8 LTD. Pembroke Road 1-1, Doshomachi 4-chome Sevenoaks, Kent TN13 1XR (GB) Chuo-ku, OSAKA (JP) (54) Prolonged release preparation and polymers thereof. (57) 1. A polymer for a prolonged release preparation which comprises (A) a polylactic acid and (B) a copolymer of glycolic acid and a hydroxycarboxylic acid of general formula R I HOCHCOOH wherein R stands for an alkyl group having 2 to 8 carbons, and wherein the weight ratio of (A) and (B) is in the range of 1 0/90 to 90/1 0. The drug is released at a constant rate from the preparation over the total release period without a large burst at the initial stage. Furthermore, the drug release period of the preparation can be freely controlled by varying the blending ratio of (A) and (B).
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • Antipyretic/Analgesic Composition Fiebersenkende/Schmerzstillende Zusammensetzung Composition Antipyrétique/Analgésique
    (19) TZZ _T (11) EP 2 659 889 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/46 (2006.01) A61K 31/192 (2006.01) 26.04.2017 Bulletin 2017/17 A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 47/32 (2006.01) (2006.01) (2006.01) (21) Application number: 11853993.1 A61K 47/36 A61K 47/38 (22) Date of filing: 28.12.2011 (86) International application number: PCT/JP2011/080383 (87) International publication number: WO 2012/091090 (05.07.2012 Gazette 2012/27) (54) ANTIPYRETIC/ANALGESIC COMPOSITION FIEBERSENKENDE/SCHMERZSTILLENDE ZUSAMMENSETZUNG COMPOSITION ANTIPYRÉTIQUE/ANALGÉSIQUE (84) Designated Contracting States: (56) References cited: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB EP-A1- 2 702 989 WO-A1-2011/093498 GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO JP-A- 2000 026 313 JP-A- 2000 344 665 PL PT RO RS SE SI SK SM TR JP-A- 2005 289 906 JP-A- 2006 225 367 JP-A- 2007 091 633 JP-A- 2007 284 423 (30) Priority: 28.12.2010 JP 2010292812 31.08.2011 JP 2011188208 • "KLUCEL®: HYDROXYPROPYLCELLULOSE, CHEMICAL AND PHYSICAL PROPERTIES", , (43) Date of publication of application: 1986, XP002726117, Retrieved from the Internet: 06.11.2013 Bulletin 2013/45 URL:http://legacy.library.ucsf.edu/documen tStore/c/n/f/cnf81a99/Scnf81a99.pdf [retrieved (73) Proprietor: Kowa Co., Ltd. on 2014-06-23] Nagoya-shi, Aichi 460-8625 (JP) • ALVAREZ-LORENZO C ET AL: "Interactions between hydroxypropylcelluloses and (72) Inventors: vapour/liquid water", EUROPEAN JOURNAL OF • KANO, Yuichiro PHARMACEUTICS AND BIOPHARMACEUTICS, Fuji-shi ELSEVIER SCIENCE PUBLISHERS B.V., Shizuoka 417-8650 (JP) AMSTERDAM, NL, vol.
    [Show full text]